Deutsche Bank’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$515K Buy
31,753
+4,680
+17% +$82.8K ﹤0.01% 2560
2025
Q4
$507K Buy
27,073
+1,422
+6% +$23.6K ﹤0.01% 2566
2025
Q3
$375K Hold
25,651
﹤0.01% 2703
2025
Q2
$283K Buy
25,651
+398
+2% +$3.87K ﹤0.01% 2768
2025
Q1
$226K Sell
25,253
-21,297
-46% -$198K ﹤0.01% 2892
2024
Q4
$438K Buy
46,550
+15,608
+50% +$142K ﹤0.01% 2677
2024
Q3
$249K Buy
30,942
+8,881
+40% +$76.9K ﹤0.01% 2811
2024
Q2
$187K Sell
22,061
-5,771
-21% -$52.1K ﹤0.01% 2838
2024
Q1
$250K Buy
27,832
+433
+2% +$4.01K ﹤0.01% 2713
2023
Q4
$308K Sell
27,399
-736
-3% -$7.41K ﹤0.01% 2640
2023
Q3
$243K Buy
28,135
+4,138
+17% +$40K ﹤0.01% 2648
2023
Q2
$248K Sell
23,997
-23,891
-50% -$264K ﹤0.01% 2764
2023
Q1
$520K Buy
47,888
+5,929
+14% +$62.7K ﹤0.01% 2468
2022
Q4
$471K Buy
41,959
+11,896
+40% +$125K ﹤0.01% 2471
2022
Q3
$305K Sell
30,063
-10,511
-26% -$98.5K ﹤0.01% 2681
2022
Q2
$368K Sell
40,574
-1,792
-4% -$16.5K ﹤0.01% 2781
2022
Q1
$406K Sell
42,366
-3,503
-8% -$34.3K ﹤0.01% 2875
2021
Q4
$507K Buy
45,869
+5,768
+14% +$50.3K ﹤0.01% 2842
2021
Q3
$297K Buy
40,101
+2,863
+8% +$32K ﹤0.01% 3347
2021
Q2
$541K Sell
37,238
-167,048
-82% -$3.14M ﹤0.01% 3169
2021
Q1
$4.17M Sell
204,286
-10,685
-5% -$203K ﹤0.01% 1656
2020
Q4
$3.82M Sell
214,971
-46,771
-18% -$840K ﹤0.01% 1503
2020
Q3
$3.87M Sell
261,742
-220,279
-46% -$4.13M ﹤0.01% 1377
2020
Q2
$10.1M Buy
482,021
+5,635
+1% +$145K 0.01% 974
2020
Q1
$11M Buy
476,386
+434,938
+1,049% +$10.9M 0.01% 880
2019
Q4
$1.07M Buy
41,448
+28,519
+221% +$554K ﹤0.01% 2334
2019
Q3
$250K Sell
12,929
-14,514
-53% -$293K ﹤0.01% 3053
2019
Q2
$446K Sell
27,443
-28,951
-51% -$587K ﹤0.01% 3345
2019
Q1
$1.28M Buy
56,394
+4,000
+8% +$101K ﹤0.01% 2830
2018
Q4
$1.34M Sell
52,394
-140,498
-73% -$3.79M ﹤0.01% 2678
2018
Q3
$6.3M Buy
192,892
+71,522
+59% +$1.95M ﹤0.01% 2003
2018
Q2
$2.75M Buy
121,370
+12,075
+11% +$287K ﹤0.01% 2736
2018
Q1
$2.65M Buy
109,295
+545
+0.5% +$15K ﹤0.01% 2683
2017
Q4
$3.03M Buy
108,750
+49,137
+82% +$1.45M ﹤0.01% 2445
2017
Q3
$2.04M Buy
59,613
+1,337
+2% +$43.7K ﹤0.01% 2522
2017
Q2
$2.32M Buy
58,276
+39,558
+211% +$1.52M ﹤0.01% 2465
2017
Q1
$688K Sell
18,718
-59,989
-76% -$1.92M ﹤0.01% 2902
2016
Q4
$2.51M Buy
78,707
+30,768
+64% +$954K ﹤0.01% 2113
2016
Q3
$1.74M Buy
47,939
+329
+0.7% +$9.16K ﹤0.01% 2449
2016
Q2
$1.08M Buy
47,610
+7,218
+18% +$156K ﹤0.01% 2829
2016
Q1
$756K Buy
40,392
+11,667
+41% +$191K ﹤0.01% 2973
2015
Q4
$467K Buy
28,725
+6,863
+31% +$109K ﹤0.01% 3312
2015
Q3
$238K Sell
21,862
-219,691
-91% -$2.8M ﹤0.01% 3716
2015
Q2
$3.14M Buy
241,553
+222,133
+1,144% +$3.45M ﹤0.01% 2128
2015
Q1
$334K Sell
19,420
-258,789
-93% -$4.74M ﹤0.01% 3516
2014
Q4
$4.15M Buy
278,209
+178,068
+178% +$3.1M ﹤0.01% 2098
2014
Q3
$2.31M Sell
100,141
-33,851
-25% -$982K ﹤0.01% 2421
2014
Q2
$4.27M Buy
+133,992
New +$4.03M ﹤0.01% 1932

Other funds holding TBPH